MICHELLE LIN
Michelle is currently an M.D. candidate at Stanford University School of Medicine. She graduated from the University of Washington in 2020 with a degree in Biology. Before medical school, Michelle spent several years studying viral genomics and developing computational tools for next-generation sequencing analysis, which were used extensively for COVID-19 surveillance sequencing in Washington state and phase III clinical trials for development of novel vaccines. Currently, her research in the Sarin Lab focuses on the genetics of skin disease. In her spare time, she enjoys reading novels, traveling, and crocheting.